Brett R. Hagen, Chief Accounting Officer at Kalaris Therapeutics, Inc. (KLRS), sold 1,915 shares at $6.72 ($13K) on 2026-03-20, disclosed to the SEC on 2026-03-23.
Open-market sale of $13k KLRS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALVR | SELL | 2025-01-27 | $342 | — | Filing → |
| ALVR | SELL | 2025-01-13 | $146 | — | Filing → |
| ALVR | SELL | 2024-11-20 | $305 | — | Filing → |